The following pages link to bisphosphonate (Q412205):
Displayed 50 items.
- osteoporosis (Q165328) (← links)
- ibandronic acid (Q166825) (← links)
- risedronic acid (Q408724) (← links)
- alendronic acid (Q420057) (← links)
- pamidronic acid (Q627499) (← links)
- etidronic acid (Q2758338) (← links)
- tiludronic acid (Q2823312) (← links)
- Category:Bisphosphonates (Q8302171) (← links)
- Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis (Q21132670) (← links)
- Development of bisphosphonates (Q21195188) (← links)
- Direct effects of bisphosphonates on breast cancer cells (Q24802079) (← links)
- The present and future role of bisphosphonates in the management of patients with breast cancer (Q24802100) (← links)
- Actions of bisphosphonates in animal models of breast cancer (Q24802119) (← links)
- Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data (Q26771537) (← links)
- Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence (Q26795493) (← links)
- Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature (Q26801348) (← links)
- Zoledronic acid as an adjuvant therapy in patients with breast cancer: a systematic review and meta-analysis (Q26861745) (← links)
- Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases (Q26997330) (← links)
- The role of bisphosphonate in the treatment of bone metastases from prostate cancer (Q27006049) (← links)
- Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis. (Q27693291) (← links)
- Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report (Q28079912) (← links)
- zoledronic acid monohydrate (Q28852343) (← links)
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials (Q30982699) (← links)
- Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment? (Q33739204) (← links)
- Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG). (Q33898576) (← links)
- Prevention of bone metastases and management of bone health in early breast cancer. (Q34613485) (← links)
- Anti-tumour activity of bisphosphonates in preclinical models of breast cancer. (Q34613492) (← links)
- Are bisphosphonates effective in the treatment of osteoarthritis pain? A meta-analysis and systematic review (Q34984018) (← links)
- Tumour macrophages as potential targets of bisphosphonates. (Q35547309) (← links)
- Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients. (Q35989786) (← links)
- The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis (Q36337775) (← links)
- Risks and benefits of bisphosphonates (Q36696538) (← links)
- Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis (Q37418209) (← links)
- Use of bisphosphonates in metastatic breast cancer: single institution review at the Dr. H. Bliss Murphy Cancer Centre (Q38075447) (← links)
- Chronic Myeloid Leukemia Associated Hypercalcemia: A Case Report and Literature Review. (Q39151826) (← links)
- Factors influencing the distribution of 99m-technetium methylene diphosphonate in bone and soft tissues (Q39226689) (← links)
- Hepatic uptake of Tc-99m-labeled diphosphonate in amyloidosis: case report (Q39458098) (← links)
- Bone scintigraphy with Tc-99m methylene diphosphonate: a comparison with ethane-hydroxy-diphosphonate (author's transl) (Q39624557) (← links)
- Atypical form of melorheostosis improved by pamidronate (Q45964144) (← links)
- Osteitis induced by chemotherapy: a case report (Q53669021) (← links)
- Bisphophonates in CKD patients with low bone mineral density. (Q54313739) (← links)
- Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion (Q57105768) (← links)
- Thyrotoxicosis revelated by bilateral hip fracture (Q79245607) (← links)
- Predictifs factors of the algodystrophy evolution in a rheumatology department among 60 cases (Q81804718) (← links)
- Bisphosphonates: indications in bone diseases other than osteoporosis (Q84382824) (← links)
- Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan (2002-08-31) (Q86247537) (← links)
- Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan (2004-06-30) (Q86247606) (← links)
- Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide (1998-12-31) (Q86250747) (← links)
- Predictive Score For Maxillary Osteonecrosis After Invasive Oral Surgery (Q86252702) (← links)
- Exploring Efficacy, Cost Effectiveness and Experiences Related to Adherence of Different Bisphosphonate Regimens for the Prevention of Osteoporotic Fragility Fractures. (Q87929830) (← links)